June 04, 2019
Quanterix is re-engineering ultrasensitivity with the launch of the Simoa HD-X Analyzer™, the latest model fully automated Simoa bead-based immunoassay platform.
Simoa assays are designed for the HD-1/HD-X Analyzer, the SR-X Ultra-Sensitive Biomarker Detection System and the SP-X Imaging and Analysis System to provide researchers ultra-sensitive analysis of protein concentration with the high precision and performance required to meet the needs of discov
Simoa assays can detect biomarkers associated with brain injury and disease at much earlier stages to understand the long term effects and disease pathology.
The Quanterix SR-X is the latest instrument powered by Simoa® technology offering researchers access to ultra-sensitive biomarker detection capabilities in a compact affordable system.
The Simoa p24 Antigen Assay is an ultra-sensitive digital immunoassay providing 1,000 times improvement in detection limits compared with a traditional ELISA. The method can be used to detect early reactivation of infectious virus from latent reservoirs and determine efficacy of drugs and therap